A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants

NCT06889701 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Periprosthetic Joint Infection (PJI)

Interventions

DRUG: TNP-2092 for injection
DRUG: Vancomycin Hydrochloride for Injection (IA)
DRUG: Vancomycin Hydrochloride for Injection (IV)
DRUG: Oral antibiotics
DRUG: Background Treatment

Sponsor

TenNor Therapeutics Inc.

Collaborators

[object Object]